About Araceli Biosciences
Araceli Biosciences is a company based in United States founded in 2020. Araceli Biosciences has raised $15.95 million across 3 funding rounds from investors including Bill Cortelyou. Araceli Biosciences offers products and services including Endeavor Automation and Clairvoyance Software. Araceli Biosciences operates in a competitive market with competitors including Lodestone Biomedical, BioImage, BioAmp Diagnostics, HAWK Biosystems and Genosaber, among others.
- Headquarter United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$15.95 M (USD)
in 3 rounds
-
Latest Funding Round
$11.2 M (USD), Seed
Apr 24, 2025
-
Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Araceli Biosciences
Araceli Biosciences offers a comprehensive portfolio of products and services, including Endeavor Automation and Clairvoyance Software.
Hardware for rapid plate scanning in drug discovery processes
Software for advanced image analysis in therapeutic research
People of Araceli Biosciences
Unlock access to complete
Funding Insights of Araceli Biosciences
Araceli Biosciences has successfully raised a total of $15.95M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $11.2 million completed in April 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Araceli Biosciences
Araceli Biosciences has secured backing from 1 investor, including angel investors. Prominent investors backing the company include Bill Cortelyou.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
BC
Bill Cortelyou |
-
|
Locked | Locked | Locked |
Investor details for Araceli Biosciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Araceli Biosciences
Investment portfolio details for Araceli Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Araceli Biosciences
Detailed financials for Araceli Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Araceli Biosciences Comparisons
Peer comparison for Araceli Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Araceli Biosciences
Araceli Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Lodestone Biomedical, BioImage, BioAmp Diagnostics, HAWK Biosystems and Genosaber, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of magnetic nanoparticle platform technology for in vivo biomarker monitoring in immuno-oncology
|
|
| Locked | Locked | Locked |
Bioassays are developed for biopharmaceutical firms and research organizations.
|
|
| Locked | Locked | Locked |
Developers of diagnostic tests that help to treat patient with a specific antibiotic
|
|
| Locked | Locked | Locked |
Clinical assays are developed for quantifying novel biomarkers in samples.
|
|
| Locked | Locked | Locked |
Diagnostic tools for detecting circulating tumor cells are developed.
|
Detailed competitors of Araceli Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Araceli Biosciences
Complete news archive for Araceli Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Araceli Biosciences
Araceli Biosciences was founded in 2020 and raised its 1st funding round 3 years after it was founded.
Araceli Biosciences is headquartered in United States.
Araceli Biosciences is a funded company, having raised a total of $15.95M across 3 funding rounds to date.
Developer of scientific tools for tissue and cell-based biomarker discovery drug development. The company is involved in the development of an instrumentation system to improve precision analysis of products by using artificial intelligence. It has developed an endeavor molecular imaging device that helps to identify cell counting, cell cycle, cell differentiation, cell morphology, cell viability, and many more.
Araceli Biosciences's top competitors include Lodestone Biomedical, BioAmp Diagnostics and BioImage.
Araceli Biosciences offers Endeavor Automation and Clairvoyance Software.
Araceli Biosciences has 1 investor. Key investors include Bill Cortelyou.